Neuralink’s first human patient able to use mouse…:
Elon Musk is the visionary behind Neuralink. He announced that the first human recipient of the company’s brain chip implant has fully recovered. The individual has demonstrated the ability to use a computer mouse solely through thoughts. Watch this video for all details.
#Neuralink #ElonMusk #WION
Recorded earlier
A robotic spacecraft is expected to touch down on the moon’s surface Thursday night, in what will mark the United States’s first uncrewed commercial moon landing.
Toward widespread SPAD sensors for night vision and other uses.
Discover how Artilux’s new GeSi SPAD, operating at room temperature, revolutionizes CMOS-based SWIR sensing and imaging technology. Explore the applications, implications, and the new standard set in photonics.
In pursuing quantum networking technologies, single-photon emitters in acoustic cavities are a promising pathway that enables the conversion and transfer of quantum information across multiple platforms. The recent discovery of single-photon emitters within two-dimensional (2D) materials, such as WSe and hexagonal boron nitride (h-BN), opens new avenues in exploring such quantum optomechanical phenomena in lower dimensional systems. In this work, we demonstrate the integration of 2D-based single-photon emitters with surface acoustic wave optomechanical cavities and illustrate their potential for radio-frequency electronic control of quantum light emission.
Using simple exfoliation techniques, WSe and h-BN layers are transferred onto surface acoustic wave cavities patterned on lithium niobate—a highly piezoelectric host material. Using electro-optical measurements, we confirm high-quality resonators and cavity-phonon modes that couple to the 2D quantum emitters. Remarkably, the interaction between the 2D emitters and acoustic waves is exceptionally strong owing to the ultrathin nature of the 2D materials and their proximity to the surface waves, verified through quantum spectroscopy measurements. In addition to the radio-frequency acoustic modulation of the emitters in these materials, new physics emerges from the emitter-phonon coupling that leads to new mechanisms for high-speed manipulation of quantum emitters, opening avenues for the generation of entangled-photon pairs.
These advancements set the stage for the exploration of cavity optomechanics with 2D materials. In future experiments, higher frequency resonators will enable studies of the interplay and dynamics between single photons and phonons deep in the quantum regime, a key technology for quantum networking.
Researchers have unraveled how mutations in a gene can lead to an incurable neurodevelopmental disorder that causes abnormal brain development in newborns and infants.
The WEHI study is the first to prove that a protein called Trabid helps control neuronal development, and that mutations to this protein can lead to microcephaly —a condition where a baby’s brain is smaller than expected.
It’s hoped the milestone findings will provide a deeper understanding into the protein’s impact on healthy development and lead to treatments that can slow or stop the development of microcephaly and potentially other neurological disorders.
🧬 🔬 💉
Review synthesizes research on NK cells’ role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.
“We create the lowest power performance technology,” said Dipti Vachani, senior VP and general manager for Arm’s automotive business, in an interview, “so that Nuro can then take advantage of all that AI software.”
Nuro was founded in 2016 by Dave Ferguson and Jiajun Zhu, two veterans of the Google self-driving car project that would go on to become Waymo. It is one of the few companies operating fully driverless vehicles — that is, vehicles without safety drivers behind the wheel — on public roads today.
In 1940, 12 years after Alexander Fleming discovered penicillin, microbiologists made a concerning discovery: a strain of the bacteria Escherichia coli had developed resistance to the new, life-saving drug. Antibiotic resistance of disease-causing bacteria is now a global problem, with bacteria continually evolving mechanisms that prevent such drugs from killing the organisms or inhibiting their growth. Now Vanderlei Bagnato of the University of São Paulo and his colleagues have developed a light-based approach that could help reduce this trend in a Staphylococcus bacterium that can cause skin infections and pneumonia [1]. The researchers presented their technique at the recent SPIE Photonics West 2024 conference in San Francisco.
If the current trend continues, epidemiologists predict that the number of people infected by antibiotic-resistant bacteria will reach 225 million worldwide by 2030. By 2050 these bacteria will cause 10 million deaths annually. Studies show that infections acquired in hospital are increasingly prone to this problem. “People are dying every day in [intensive care wards] from resistant bacteria. If someone acquires pneumonia, and antibiotics don’t work, they’re in trouble,” Bagnato says.
One route to tackling antibiotic resistance is to develop new drugs, which is a costly process. Another route—and one that is becoming increasingly popular—is to inhibit antibiotic-eluding mechanisms that a bacterium develops as it evolves. This inhibition can be achieved using light, a process those in the field call photodynamics, and the route Bagnato and his colleagues have taken. “We’re using photodynamics to reverse resistance so that antibiotics can act again,” he says.
